LexisNexis creates a real-world data network with medical partners

Healthcare analytics company LexisNexis Risk Solutions has developed what it calls an interoperable real-world data center powered by micro-data link technology and unidentified data sets from data partners.

The first group of companies to join the Gravitas network includes data sets for precision medicine and health equity studies. Paired with data assets from LexisNexis Risk Solutions, the company said, it enables more comprehensive and advanced clinical research, ultimately improving health outcomes.

The company said the network provides access to deidentified, clinically curated data that can be precisely correlated, enabling researchers to uncover the insights they need to develop effective and safe treatments for the people who need them most.

The Gravitas Network includes a comprehensive, clinically-defined dataset for patient-level social determinants of health (SDoH), a robust and current mortality dataset, and one of the largest multi-source, unidentified medical claims datasets in the United States. by “Gravitas Token,” which LexisNexis describes as “a next generation, HIPAA compliant token that securely links uncharacterized datasets with increasing accuracy.” While other tokens bind data using probabilistic matching, the company notes that the Gravitas token takes advantage of a reference data layer to help ensure the correct records are matched and correlated accurately over time.

Organizations that join the Gravitas Network include:

• Trovita Truveta is an early adopter of the Gravitas Token, a group of 24 US health systems that account for 16 percent of clinical data in the US. Claims data to advance patient care and improve health equity.

• graciousness – Ovation, a genomic clinic data company, is developing one of the world’s first platforms for large-scale generation and delivery of human genomic data. Ovation contains more than 1 million geographically diverse biotypes from more than 425,000 unique patients, representing a wide range of disease regions. The Gravitas Ovation code enables non-precisely identified genome data to be linked to additional phenotype data sources, so they can help life sciences organizations develop biomarkers and develop targeted discovery. Ed Stepansky, PhD, general manager, Data at Ovation, said with the current situation. “Being part of the Gravitas Network is an exciting opportunity to advance our vision to unlock the promise of precision medicine for patients across disease regions.”

Solis Mammography – For more than 35 years, Solis has been the largest independent breast imaging provider in the United States focused on detecting early-stage breast cancers through annual checkups. Linking longitudinal imaging data to complementary clinical and genomic data on Gravitas Token for in-depth breast cancer research is in line with Solis Mammography’s mission to support women’s long-term health and wellness.

• PointClickCare It is a healthcare technology platform that enables meaningful collaboration and access to real-time insights. With more than 20 years of real-world data in Long-Term and Post-Acute Care (LTPAC), the company helps life sciences organizations improve scientific research with Protected Unidentified Health Information (PHI). In collaboration with the Gravitas Network, the result-rich datasets will continue to assist clinical research in the areas of early warning, mitigation of disease spread, finding treatments and evaluating treatment options for various conditions affecting vulnerable populations.

• Institute of Health Metrics – The IHM Clinical Data Platform, a collaboration between community hospitals across the United States, uses the breadth of Gravitas Core datasets and the network to advance nationwide health equity initiatives and clinical research in communities that are often underrepresented in the medical literature.

“We see a tremendous opportunity to leverage our core datasets and advanced connectivity technology to create more real-world, people-centric data to advance clinical research and improve the future of healthcare,” said Jeff Diamond, president and general manager of the healthcare business at LexisNexis Risk Solutions, in a statement.

Leave a Comment